ADX-914-XL
/ Q32 Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 05, 2026
Today, Q32 Bio announced that ADX-914-XL, a fully human half-life extended anti-IL-7Rα antibody designed to re-regulate adaptive immune function by blocking IL-7 and TSLP signaling, is advancing in pre-clinical development.
(PRNewswire)
Pipeline update • Immunology
1 to 1
Of
1
Go to page
1